Biomarkers for TB treatment response: challenges and future strategies.
about
Advances and hurdles on the way toward a leprosy vaccine.Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapyA subset of circulating blood mycobacteria-specific CD4 T cells can predict the time to Mycobacterium tuberculosis sputum culture conversionCytokine Kinetics in the First Week of Tuberculosis Therapy as a Tool to Confirm a Clinical Diagnosis and Guide TherapyEffect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis.Cytokine response to selected MTB antigens in Ghanaian TB patients, before and at 2 weeks of anti-TB therapy is characterized by high expression of IFN-γ and Granzyme B and inter- individual variationModulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cureHost targeted activity of pyrazinamide in Mycobacterium tuberculosis infectionMycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatmentT cell monitoring of chemotherapy in experimental rat tuberculosis.T lymphocyte surface expression of exhaustion markers as biomarkers of the efficacy of chemotherapy for tuberculosisCDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosisNew diagnostic methods for tuberculosis.A metabolic biosignature of early response to anti-tuberculosis treatment.In vitro and in vivo studies of a rapid and selective breath test for tuberculosis based upon mycobacterial CO dehydrogenase.Biomarkers of latent TB infection.Surrogate markers of infection: interrogation of the immune system.Animal Models for Tuberculosis in Translational and Precision Medicine.Total IgM and Anti-Phosphatidylcholine IgM Antibody Secretion Continue After Clearance of Mycobacterium bovis Bacillus Calmette-Guerin Pleural Infection.The role of metabolomics in tuberculosis treatment research.Predicting tuberculosis treatment outcome using metabolomics.Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis.
P2860
Q22305432-F15C1976-8973-479C-AD6E-95F09D31AB10Q28484173-E55CAC3E-0427-412E-9904-60D8CF6B2A86Q28541001-589AAE6B-1718-491E-AA14-C6894A62B04BQ28545824-4F4AC670-10EA-4C29-B232-A334BFD9420FQ28729980-483F6A34-4143-41D9-A533-FF856464C933Q33678888-D9821D6E-4E48-45A6-B73A-422EB3E1A915Q34270741-8145D647-CB0E-4CE8-8C3B-0A8EBEB87E93Q34905582-72237CE1-2A59-4EFE-88B6-39C2EB58C080Q34981779-BCB600DE-3C85-4982-92B5-2DDF2F2756BBQ35063982-2D0A0F90-7FEB-4825-BBA8-AF0ABCBEAC11Q35139430-A59750D6-E8D4-497A-95D7-E95CF777FC82Q35164131-B47BED43-C0C0-43E6-BE91-92FFABD4A427Q35528462-665292B3-44EC-4EDA-93A6-0BA754DE1AAEQ37051057-6C79F42B-DF68-4E70-B344-F0F4E23F74A8Q37414160-E374C7D3-CBB5-40A7-9428-7F79B9435EA7Q37569320-26907B21-5F97-4041-9989-CBE0C65F2A2FQ37714067-4BD24C04-5AF6-4AB1-AA67-70D56314F669Q37755029-A15B2418-2E31-4697-B3AE-A1E05A4F1E6DQ37862743-28865D7C-E7FB-4126-85E0-6FF6693DF824Q38681974-EA6E84C0-D30F-4B5A-B26F-34D03B4217D0Q40196451-FF3C7939-77EA-4989-A912-E17EEF03A6FAQ46462804-7537471A-0407-4C80-97C7-3625C4768D9EQ49668458-AC7A670C-4DBF-4371-BFAC-DB21EAE6B3B7Q55311633-5A15B7D2-97BB-4855-8CDC-A2CA200D107E
P2860
Biomarkers for TB treatment response: challenges and future strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biomarkers for TB treatment response: challenges and future strategies.
@en
Biomarkers for TB treatment response: challenges and future strategies.
@nl
type
label
Biomarkers for TB treatment response: challenges and future strategies.
@en
Biomarkers for TB treatment response: challenges and future strategies.
@nl
prefLabel
Biomarkers for TB treatment response: challenges and future strategies.
@en
Biomarkers for TB treatment response: challenges and future strategies.
@nl
P50
P1433
P1476
Biomarkers for TB treatment response: challenges and future strategies.
@en
P304
P356
10.1016/J.JINF.2008.06.007
P577
2008-07-22T00:00:00Z